LCB-03-110

N/A

Report date: 2025/06/11 10:52:19
NME

Base Information

Drug NameLCB-03-110
Drug Alias NameLCB-03-110LCB-03-0110
ClassificationSmall molecules
Mechanisms of ActionDiscoidin domain receptors inhibitorsTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRCDiscoidin domain receptors
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeorgetown University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesGeorgetown University Medical Center
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A